CJC-1295 research guide for Adelphi. Covers DAC vs no-DAC forms, half-life differences, purity testing, and how to source quality CJC-1295 for research.
Most researchers trying to source CJC-1295 in Adelphi quickly find that local retail options are all but absent from local stores. The practical takeaway for Adelphi researchers: sourcing CJC-1295 comes down completely to vendor quality evaluation, not geography — and the evaluation methodology is universal across all locations. What consistently distinguishes top CJC-1295 vendors is full COA coverage: HPLC for purity, mass spec for identity and weight verification, and endotoxin testing for contamination assurance. The sections below cover what Adelphi researchers need to know about sourcing, verifying, and handling CJC-1295 for research purposes.
How CJC-1295 Works — Mechanisms & Research
CJC-1295 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Adelphi studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
CJC-1295 Purchasing Guide
The first step for any Adelphi researcher sourcing CJC-1295 is locating suppliers that experienced researchers actively recommend — search results alone are too heavily influenced by marketing spend. Mass spectrometry in the COA confirms that the main HPLC peak is actually CJC-1295 and not a structurally similar impurity — HPLC purity alone cannot verify molecular identity. Strong quality indicators beyond COA quality: established track record of at least two years, customer service that can discuss analytical methods, and shipping with desiccant and appropriate cold protection. Price is an unreliable primary filter for CJC-1295 quality — research-grade synthesis and testing has genuine production costs that cannot be cut without consequences, so unusually low prices consistently indicate quality reductions.
Order CJC-1295 — ships to Adelphi
COA-verified · International tracking · Research grade
All use of CJC-1295 in Adelphi or anywhere constitutes research use — this compound is not approved for human therapeutic use, and all handling should follow research laboratory protocols. Reconstitute CJC-1295 with bacteriostatic water at a concentration matched to your dosing requirements; a standard 5mg in 2mL gives a 2.5mg/mL solution — or 25mcg per insulin syringe unit. Quality CJC-1295 sourcing is inseparable from safety — bacterial endotoxin contamination, mislabeling, and degradation products are all safety issues that verified-quality sourcing directly prevents. For any individual considering CJC-1295 outside a formal research context: consult a qualified physician — this compound is not a licensed human medication and its known risks are not comparable to approved pharmaceuticals.
Frequently Asked Questions
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
